Literature DB >> 16873637

Origins of HIV and the evolution of resistance to AIDS.

Jonathan L Heeney1, Angus G Dalgleish, Robin A Weiss.   

Abstract

The cross-species transmission of lentiviruses from African primates to humans has selected viral adaptations which have subsequently facilitated human-to-human transmission. HIV adapts not only by positive selection through mutation but also by recombination of segments of its genome in individuals who become multiply infected. Naturally infected nonhuman primates are relatively resistant to AIDS-like disease despite high plasma viral loads and sustained viral evolution. Further understanding of host resistance factors and the mechanisms of disease in natural primate hosts may provide insight into unexplored therapeutic avenues for the prevention of AIDS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16873637     DOI: 10.1126/science.1123016

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  60 in total

1.  Vif substitution enables persistent infection of pig-tailed macaques by human immunodeficiency virus type 1.

Authors:  Rajesh Thippeshappa; Patricia Polacino; Monica T Yu Kimata; Edward B Siwak; David Anderson; Weiming Wang; Laura Sherwood; Reetakshi Arora; Michael Wen; Paul Zhou; Shiu-Lok Hu; Jason T Kimata
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

Review 2.  Viral subversion mechanisms in chronic kidney disease pathogenesis.

Authors:  Leslie A Bruggeman
Journal:  Clin J Am Soc Nephrol       Date:  2007-07       Impact factor: 8.237

3.  Infectious diseases: An ill wind for wild chimps?

Authors:  Robin A Weiss; Jonathan L Heeney
Journal:  Nature       Date:  2009-07-23       Impact factor: 49.962

Review 4.  Cross-species virus transmission and the emergence of new epidemic diseases.

Authors:  Colin R Parrish; Edward C Holmes; David M Morens; Eun-Chung Park; Donald S Burke; Charles H Calisher; Catherine A Laughlin; Linda J Saif; Peter Daszak
Journal:  Microbiol Mol Biol Rev       Date:  2008-09       Impact factor: 11.056

5.  Positive selection on HIV accessory proteins and the analysis of molecular adaptation after interspecies transmission.

Authors:  André E R Soares; Marcelo A Soares; Carlos G Schrago
Journal:  J Mol Evol       Date:  2008-05-09       Impact factor: 2.395

Review 6.  Evolution in health and medicine Sackler colloquium: Evolution and public health.

Authors:  Gilbert S Omenn
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-04       Impact factor: 11.205

7.  Genome-wide association study implicates PARD3B-based AIDS restriction.

Authors:  Jennifer L Troyer; George W Nelson; James A Lautenberger; Leslie Chinn; Carl McIntosh; Randall C Johnson; Efe Sezgin; Bailey Kessing; Michael Malasky; Sher L Hendrickson; Guan Li; Joan Pontius; Minzhong Tang; Ping An; Cheryl A Winkler; Sophie Limou; Sigrid Le Clerc; Olivier Delaneau; Jean-François Zagury; Hanneke Schuitemaker; Daniëlle van Manen; Jay H Bream; Edward D Gomperts; Susan Buchbinder; James J Goedert; Gregory D Kirk; Stephen J O'Brien
Journal:  J Infect Dis       Date:  2011-05-15       Impact factor: 5.226

8.  An HER2 DNA vaccine with evolution-selected amino acid substitutions reveals a fundamental principle for cancer vaccine formulation in HER2 transgenic mice.

Authors:  Richard F Jones; Joyce D Reyes; Heather M Gibson; Jennifer B Jacob; Ulka Vaishampayan; Stuart Ratner; Kang Chen; Wei-Zen Wei
Journal:  Cancer Immunol Immunother       Date:  2019-06-08       Impact factor: 6.968

9.  Evidence for a different susceptibility of primate lentiviruses to type I interferons.

Authors:  Stéphanie Cordeil; Xuan-Nhi Nguyen; Gregory Berger; Stéphanie Durand; Michelle Ainouze; Andrea Cimarelli
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

10.  NKp44 expression, phylogenesis and function in non-human primate NK cells.

Authors:  Andrea De Maria; Elisabetta Ugolotti; Erik Rutjens; Stefania Mazza; Luana Radic; Alessandro Faravelli; Gerrit Koopman; Eddi Di Marco; Paola Costa; Barbara Ensoli; Aurelio Cafaro; Maria Cristina Mingari; Lorenzo Moretta; Jonathan Heeney; Roberto Biassoni
Journal:  Int Immunol       Date:  2009-01-15       Impact factor: 4.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.